Derivative exercise or conversion — not an open-market buy.
Traded Jan 23, 2026 · Filed Jan 27, 2026
Travelers Companies (The)'s & Pres., Bond & Spec. Ins. sold $4.68M of Travelers Companies (The) shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$4,675,593
Shares × reported transaction price
2 days after results of Jan 21, 2026, 83 days before results of Apr 16, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $277.72 on Jan 23, 2026, 19% above its 52-week low and 6% below its high, little changed over the previous 30 trading days
52-week range $233.83 (Apr 7, 2025) to $294.52 (Nov 26, 2025), 72% of the way up, from 251 adjusted closes. 30 trading days earlier: $279.16 on Dec 9, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.5% | -0.9% | +3.3% |
| 30 days | +8.9% | -0.9% | +9.8% |
| 90 days | +8.0% | +2.8% | +5.2% |
| 180 days | +38.8% | +6.3% | +32.5% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Travelers Companies (The)'s Vice Chairman sold $304K of Travelers Companies (The) shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.